Hantz Financial Services »

Lineage Cell Therapeutics In shares owned by Hantz Financial Services

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Hantz Financial Services from 13F filings

Historical chart of Hantz Financial Services investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Hantz Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Hantz Financial Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $0 29 0.00
2025-09-30 $0 29 0.00
2025-06-30 $0 29 0.00
2025-03-31 $0 29 0.00
2024-12-31 $0 29 0.00
2024-06-30 $0 29 0.00
2024-03-31 $0 29 0.00
2023-12-31 $0 29 0.00
2023-09-30 $0 29 0.00
2023-06-30 $0 29 0.00
2023-03-31 $0 29 0.00
2022-12-31 $0 29 0.00
2022-09-30 $0 29 0.00
2022-06-30 $0 29 0.00
2022-03-31 $0 29 0.00